Materials and Reagents

6-well plates (Thermo Fisher Scientific, catalog number: 130184 )
12-well plates (Thermo Fisher Scientific, catalog number: 130185 )
HEK293 cells (ATCC, catalog number: CRL-1573 )
NG108-15 cells (ATCC, catalog number: HB-12317 )
MCF-7 cells (ATCC, catalog number: HTB-22 )
[6,7-³H(N)]-RX821002 (PerkinElmer, catalog number: NET1153250UC )
[7-methoxy-³H]-Prazosin (PerkinElmer, catalog number: NET823025UC )
[5,7-³H]-CGP12177 (PerkinElmer, catalog number: NET1061250UC )
[¹²⁵I]-Angiotensin II, [¹²⁵I]-Ang II (PerkinElmer, catalog number: NEX105050UC )
[N-methyl-³H]-Scopolamine methyl chloride, [³H]-NMS (PerkinElmer, catalog number: NET636250UC )
Phentolamine hydrochloride (Sigma, catalog number: P7547 )
Rauwolscine hydrochloride (Tocris, catalog number: 0 891 )
Alprenolol hydrochloride (Sigma, catalog number: A8676 )
Angiotensin II, Ang II (Calbiochem, catalog number: 05-23-0101 )
Atropine (Sigma, catalog number: A0132 )
Doxycycline hyclate (Sigma, catalog number: D9 891 )
Dulbecco’s modified Eagle’s medium, DMEM (Sigma, catalog number: D6429-500ML )
Fetal bovine serum, FBS (HyClone, catalog number: SH30396.03 )
Penicillin-streptomycin solution (HyClone, catalog number: SH40003.01 )
Hypoxanthine (Sigma, catalog number: H9377 )
Aminopterin (Sigma, catalog number: A3411 )
Thymidine (Sigma, catalog number: T9250 )
Poly-L-lysine hydrobromide (Sigma, catalog number: P1274 )
Trypsin-EDTA (0.25%) (Sigma, catalog number: T4049-100ML )
Opti-MEM (Gibco, catalog number: 31985-070 )
Lipofectamine 2000 (Invitrogen, catalog number: 11668-019 )
10× Phosphate buffered saline, 10× PBS (Sigma, catalog number: P5493-4L )
NaOH (Sigma, catalog number: S5881-500G )
Scintillation solution, ScintiVerse^TM BD cocktail (Fisher Chemical, catalog number: SX18-4 )
High density polyethylene vials, 20 ml capacity (RPI, catalog number: 121043 )
Poly-L-lysine (see Recipes)
NG108-15 growth medium (see Recipes)
DMEM complete medium (see Recipes)
³H-RX821002 binding solution (see Recipes)
³H-RX821002 binding solution containing 10 µM rauwolscine (see Recipes)

Equipment

Low speed orbital shaker (Southwest Science, catalog number: SBT30 )
Hemocytometer (Hausser Scientific, catalog number: 1483 )
Cell culture incubator (Thermo Scientific, Forma series II water jacketed CO₂ incubator)
Tissue culture microscope (Nikon, model: Eclipse TS100 )
Scintillation counter (Hitachi, model: AccuFLEX LSC-8000c )

Software

Microsoft Excel

Procedure

Quantification of endogenous α_2B-AR at the cell surface
There are three different α₂-AR subtypes: α_2A-AR, α_2B-AR and α_2C-AR. NG108-15 neuroblastoma-glioma cells express only α_2B-AR but not α_2A-AR and α_2C-AR, whereas MCF-7 breast cancer cells express both α_2B-AR and α_2C-AR but not α_2A-AR.
1. Cell culture
  1. To pre-coat 6-well plates, add 2 ml of poly-L-lysine (Recipe 1) each well and incubate at 37 °C for 15 min. Wash the plate twice, each with 1 ml of sterilized MilliQ-water.
  2. Seed NG108-15 or MCF-7 cells on 6-well plates at a total of 5 × 10⁵ cells per well. For each experiment, a total of 6 wells are needed; 3 wells are used to measure total radioligand binding and other 3 wells used to measure non-specific radioligand binding.
  3. Culture NG108-15 cells in NG108-15 growth medium (Recipe 2) under 95% air and 5% CO₂ at 37 °C.
  4. Culture MCF-7 cells in DMEM complete medium (Recipe 3) under 95% air and 5% CO₂ at 37 °C.
  5. When cells become 70-90% confluent, conduct radioligand binding.
2. Radioligand binding
  1. Aspirate the growth medium completely.
  2. To measure total radioligand binding, add 500 µl of ³H-RX821002 at a concentration 2 nM diluted in DMEM (Recipe 4).
  3. To measure non-specific radioligand binding, add 500 µl of ³H-RX821002 at 2 nM containing nonradioactive rauwolscine at 10 μM (Recipe 5).
  4. Incubate cells for 90 min at room temperature (RT) on a low speed orbital shaker with constant shaking at 20-40 rpm.
  5. Aspirate radioligand binding solution and wash cells twice, each with 1 ml of 1× PBS (10× PBS diluted with MilliQ-water) for 5 min at RT with shaking to remove the excess radioligand.
  6. Remove PBS and add 500 µl of 1 M NaOH to digest cells for 2 h at RT with shaking.
  7. Add 4 ml of scintillation solution to each high density polyethylene vial, transfer cell lysates to vials, and mix vigorously by inverting the tubes or using a vortex.
  8. Count radioactivity in a scintillation counter.
  9. In a separate vial, add 4 ml of scintillation solution and 5 µl of radioligand binding solution, mix and count radioactivity. This number will be used as input to calculate receptor numbers.
Quantification of transiently expressed α_2B-AR at the cell surface
1. Cell culture
  1. Seed HEK293 cells into 6-well plates pre-coated with poly-L-lysine at a total of 5 × 10⁵ cells per well and culture cells in DMEM complete medium at 37 °C overnight.
  2. Check the cell density under a tissue culture microscope. When cells become 70-90% confluent, aspirate culture medium and add 1.8 ml of DMEM.
2. Transient transfection
  1. α_2B-AR plasmids in any mammalian expression vectors can be used. For example, we have used the pEGFP-N1 vector to generate α_2B-AR tagged with GFP at the C-terminus (Dong et al., 2010a and 2010b). Based on our experience, transfection of 1 µg of α_2B-AR plasmids in each well of 6-well plates is sufficient to achieve the maximal receptor expression.
  2. In an Eppendorf tube, add 125 µl of serum-free Opti-MEM and 1 µg of α_2B-AR plasmids, mix gently, and incubate for 5 min at RT.
  3. In another tube, add 125 µl of Opti-MEM and 2.5 µl of Lipofectamine 2000, mix and incubate for 5 min at RT.
  4. Combine two solutions, mix gently by pipetting 3-4 times, and incubate for additional 20 min at RT.
  5. Add the mixture slowly into cells cultured in 1.8 ml of DMEM, mix gently, and culture cells for 6 h at 37 °C.
  6. Remove cell culture medium and wash cells once with 1 ml of sterilized 1× PBS.
  7. Treat cells with 100 µl of trypsin-EDTA for 2 min at 37 °C and add 1 ml of DMEM complete medium.
  8. Split cells from each well of 6-well plates into four wells of 12-well plates pre-coated with poly-L-lysine (0.27 ml each well). Two wells are used to measure total radioligand binding and other two wells used to measure non-specific radioligand binding.
  9. Culture cells in DMEM complete medium for 24-36 h at 37 °C.
3. Radioligand binding
  1. Aspirate the growth medium completely.
  2. For measurement of total radioligand binding, add 200 µl of ³H-RX821002 at 20 nM diluted in DMEM (Recipe 4) into cells
  3. For measurement of non-specific radioligand binding, add 200 µl of ³H-RX821002 at 20 nM plus rauwolscine at 10 μM (Recipe 5) into cells.
  4. Incubate cells for 90 min at RT with constant shaking at 20-40 rpm.
  5. Aspirate radioligand binding solution and wash cells twice, each with 0.5 ml of 1× PBS for 5 min at RT with shaking.
  6. Remove PBS and add 500 µl of 1 M NaOH to digest cells for 2 h at RT with shaking.
  7. Transfer cell lysates to a vial containing 4 ml of scintillation solution, mix well and count radioactivity in a scintillation counter.
  8. Add 5 µl of radioligand binding solution and 4 ml of scintillation solution to a vial, mix and count radioactivity. This number will be used as input to calculate receptor numbers.
Quantification of inducibly expressed α_2B-AR at the cell surface
1. Stable HEK293 cells inducibly expressing α_2B-AR were generated by using Tet-On 3G tetracycline-inducible gene expression system as described previously (Zhang et al., 2016a and 2016b).
2. Seed cells into 12-well plates pre-coated with poly-L-lysine at a density of 2 × 10⁵ cells per well and culture cells in DMEM complete medium at 37 °C overnight.
3. To measure doxycycline dose-dependent induction of α_2B-AR expression, add doxycycline to the final concentrations of 0, 2.5, 5, 7.5, 10, 20, 40, 60, 80 and 100 ng/ml and incubate for 24 h at 37 °C.
4. To measure time-dependent induction of α_2B-AR expression, add doxycycline at the final concentration of 40 ng/ml and incubate cells for 2, 4, 6, 8, 10, 12, 14, 16, 20, 24, and 36 h.
5. Conduct radioligand binding as described in Procedure B.
Measurement of the cell surface expression of other GPCRs
Over the past years, we have used intact live-cell ligand binding assays to quantify the cell surface expression of several family A GPCRs, including α_1A-AR, α_1B-AR, α_2A-AR, α_2B-AR, α_2C-AR, β₁-AR, β₂-AR, Ang II type 1 (AT1R) and type 2 (AT2R) receptors, and M3-muscarinc receptor (M3-MR) using different radioligands (Table 1). One issue associated with intact cell radioligand binding assays is that radiolabeled ligands may be able to induce receptor internalization. For example, Ang II is an agonist of AT1R, thus incubation with ¹²⁵I-Ang II may induce the internalization of AT1R from the cell surface to the endosomal compartment. One strategy to limit receptor internalization during incubation with radiolabeled agonists is to carry out ligand binding assays at low temperature (Filipeanu et al., 2004).

Table 1. Measurement of the surface expression of GPCRs by intact cell ligand binding assays

Drugs indicated in ( ) are used for measurement of non-specific radioligand binding.
Data analysis
1. Calculate specific radioligand binding to receptors using the values of disintegrations per minute (DPM):
  
  Specific binding (DPM) = total binding (DPM) - non-specific binding (DPM)
2. Calculate surface receptor numbers per cell
  In order to calculate the receptor numbers at the surface in each cell, the total cell numbers used in ligand binding assays need to be determined. This can be done by preparing cell cultures in exactly the same way as for ligand binding and count the cell numbers in each well by using a hemocytometer.
  1. Endogenous receptors
    
    As 1 mole = 6.02 × 10²³ molecules,
    Sample ligand number per well (molecules)
    = Sample DPM × 10^-14 moles × 6.02 × 10²³ ÷ Input DPM
    = Sample DPM × 6.02 × 10⁹ ÷ total input DPM
    Sample ligand number per cell (molecules)
    = Sample DPM × 6.02 × 10⁹ ÷ total input DPM ÷ cell number
  2. Overexpressed receptors
Experimental results
1. Inducible expression of the surface expression of α_2B-AR
  By using intact live-cell radioligand binding assays as described in the section C, we have measured the surface expression of α_2B-AR in a stable HEK293 cell line which inducibly expresses α_2B-AR. Our data have shown that doxycycline incubation induces the expression of α_2B-AR at the cell surface in a dose- (Figure 1A) and time-dependent (Figure 1B) fashion. Doxycycline-induced α_2B-AR expression reaches a plateau at a concentration of about 40 ng/ml (Figure 1A) and after 20 h of induction (Figure 1B), resulting in a total of 8.5 × 10⁵ α_2B-AR at the surface per cell (Zhang et al., 2016a and 2016b).
  
  Figure 1. Dose- (A) and time-dependent (B) induction of α_2B-AR expression at the cell surface by doxycycline in HEK293 cells. The data shown are percentages of specific binding obtained from cells treated with doxycycline at 100 ng/ml (A) or from cells after induction for 36 h (B) (Zhang et al., 2016a and 2016b).
2. Structural determinants of α_2B-AR transport to the cell surface
  Over the past decades, most studies on GPCR trafficking have focused on the events involved in receptor internalization from the cell surface to the endosomal compartments and recycling of internalized receptors back to the cell surface (Tan et al., 2004; Hanyaloglu and von Zastrow, 2008; Marchese et al., 2008; Kang et al., 2014). In contrast, the molecular mechanisms underlying the cell surface transport of newly synthesized receptors along the biosynthesis pathways are much less well understood. By using intact live cell radioligand binding assays as described above, we have successfully identified a number of motifs or specific residues which are essential for receptor transport to the cell surface either from the endoplasmic reticulum (ER) or from the Golgi apparatus. For example, we have demonstrated that mutation of the residues Y12/S13 in the N-terminus, L48 in the first intracellular loop, and I443/F444 and F436 in the C-terminus markedly reduces the cell surface expression of α_2B-AR (Figure 2) (Dong and Wu, 2006; Duvernay, Dong et al., 2009a and 2009b), indicating important roles of these residues in α_2B-AR biosynthesis.
  
  Figure 2. Inhibition of the cell surface transport of α_2B-AR by mutating residues Y12/S13, L48, F436 and I443/L444. Wild-type and mutated α_2B-AR were transiently expressed in HEK293 cells and their surface expression was measured by radioligand binding of intact live cells using [³H]-RX821002.
3. Identification of α_2B-AR surface transport regulators
  We have also employed intact live cell radioligand binding assays in searching for proteins that regulate α_2B-AR cell surface transport. For instance, in recent studies we have investigated the function of 48 Rab GTPases (Li et al., 2017) and 44 putative Rab GTPase-activating proteins (GAPs) (Wei et al., 2019) in the cell surface transport of α_2B-AR. In these experiments, individual Rab mutants or Rab GAPs were transiently expressed in stable HEK293 cells expressing α_2B-AR and their effects on the cell surface expression of α_2B-AR were measured by radioligand binding of intact live cells as described above. Our results have shown that the expression of Rab43 mutants and six TBC domain-containing proteins, namely TBC1D5, TBC1D6, TBC1D8B, TBC1D20, TBC1D22A and RN-tre significantly reduces the cell surface numbers of α_2B-AR (Figure 3) (Li et al., 2017; Wei et al., 2019). These results demonstrate important functions of Rab43 and the six TBC proteins in the forward trafficking of nascent GPCRs and reveal novel regulatory mechanisms underlying GPCR targeting to the functional destination.
  
  Figure 3. Inhibition of the cell surface transport of α_2B-AR by mutated Rab43 and TBC domain-containing proteins. The Rab43 mutant or individual TBC proteins were transiently expressed in HEK293 cells stably expressing α_2B-AR and α_2B-AR expression at the surface was measured by intact cell ligand binding using [³H]-RX821002.

Recipes

Poly-L-lysine
Dissolve poly-L-lysine hydrobromide in sterilized Milli-Q water to a final concentration of 25 μg/ml
NG108-15 growth medium
DMDM
10% FBS
100 units/ml penicillin
100 μg/ml streptomycin
100 μM hypoxanthine
0.4 μM aminopterin
16 μM thymidine
DMEM complete medium
DMEM
10% FBS
100 units/ml penicillin
100 μg/ml streptomycin
³H-RX821002 binding solution
As the concentration of ³H-RX821002 varies in different batches, the following is just an example of concentration calculation of the radioligand in a vial containing 250 µCi in a total volume of 250 µl with specific activity of 63.9 Ci/mmol.

Dilute ³H-RX821002 in DMEM to 2 nM for measurement of endogenous receptors or to 20 nM for measurement of overexpressed receptors.
³H-RX821002 binding solution containing 10 µM rauwolscine
1. To prepare 5 mM rauwolscine stock solution, dissolve 19 mg of rauwolscine hydrochloride in 10 ml of Milli-Q water
2. Dilute rauwolscine stock solution to 10 µM in radioligand binding solution prepared as Recipe 4

Acknowledgments

This work was supported by the National Institutes of Health grant R35GM136397.

Competing interests

The authors declare no conflict of interests.

References

Dong, C., Nichols, C. D., Guo, J., Huang, W., Lambert, N. A. and Wu, G. (2012). A triple arg motif mediates α_2B-adrenergic receptor interaction with Sec24C/D and export. Traffic 13(6): 857-868.
Dong, C. and Wu, G. (2006). Regulation of anterograde transport of alpha2-adrenergic receptors by the N termini at multiple intracellular compartments. J Biol Chem 281(50): 38543-38554.
Dong, C. and Wu, G. (2007). Regulation of anterograde transport of adrenergic and angiotensin II receptors by Rab2 and Rab6 GTPases. Cell Signal 19(11): 2388-2399.
Dong, C., Yang, L., Zhang, X., Gu, H., Lam, M. L., Claycomb, W. C., Xia, H. and Wu, G. (2010a). Rab8 interacts with distinct motifs in α_2B- and β2-adrenergic receptors and differentially modulates their transport. J Biol Chem 285(26): 20369-20380.
Dong, C., Zhang, X., Zhou, F., Dou, H., Duvernay, M. T., Zhang, P. and Wu, G. (2010b). ADP-ribosylation factors modulate the cell surface transport of G protein-coupled receptors. J Pharmacol Exp Ther 333(1): 174-183.
Dong, C., Zhou, F., Fugetta, E. K., Filipeanu, C. M. and Wu, G. (2008). Endoplasmic reticulum export of adrenergic and angiotensin II receptors is differentially regulated by Sar1 GTPase. Cell Signal 20(6): 1035-1043.
Dunham, J. H., Meyer, R. C., Garcia, E. L. and Hall, R. A. (2009). GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions. Biochemistry 48(43): 10286-10297.
Duvernay, M. T., Dong, C., Zhang, X., Robitaille, M., Hebert, T. E. and Wu, G. (2009a). A single conserved leucine residue on the first intracellular loop regulates ER export of G protein-coupled receptors. Traffic 10(5): 552-566.
Duvernay, M. T., Dong, C., Zhang, X., Zhou, F., Nichols, C. D. and Wu, G. (2009b). Anterograde trafficking of G protein-coupled receptors: function of the C-terminal F(X)₆LL motif in export from the endoplasmic reticulum. Mol Pharmacol 75(4): 751-761.
Duvernay, M. T., Wang, H., Dong, C., Guidry, J. J., Sackett, D. L. and Wu, G. (2011). Alpha2B-adrenergic receptor interaction with tubulin controls its transport from the endoplasmic reticulum to the cell surface. J Biol Chem 286(16): 14080-14089.
Fan, Y., Li, C., Guo, J., Hu, G. and Wu, G. (2012). A single lys residue on the first intracellular loop modulates the endoplasmic reticulum export and cell-surface expression of alpha2A-adrenergic receptor. PLoS One 7(12): e50416.
Filipeanu, C. M., Zhou, F., Claycomb, W. C. and Wu, G. (2004). Regulation of the cell surface expression and function of angiotensin II type 1 receptor by Rab1-mediated endoplasmic reticulum-to-Golgi transport in cardiac myocytes. J Biol Chem 279(39): 41077-41084.
Hanyaloglu, A. C. and von Zastrow, M. (2008). Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48: 537-568.
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schioth, H. B. and Gloriam, D. E. (2017). Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 16(12): 829-842.
Hilger, D., Masureel, M. and Kobilka, B. K. (2018). Structure and dynamics of GPCR signaling complexes. Nat Struct Mol Biol 25(1): 4-12.
Kang, D. S., Tian, X. and Benovic, J. L. (2014). Role of β-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking. Curr Opin Cell Biol 27: 63-71.
Li, C., Fan, Y., Lan, T. H., Lambert, N. A. and Wu, G. (2012). Rab26 modulates the cell surface transport of α2-adrenergic receptors from the Golgi. J Biol Chem 287(51): 42784-42794.
Li, C., Wei, Z., Fan, Y., Huang, W., Su, Y., Li, H., Dong, Z., Fukuda, M., Khater, M. and Wu, G. (2017). The GTPase Rab43 controls the anterograde ER-Golgi trafficking and sorting of GPCRs. Cell Rep 21(4): 1089-1101.
Marchese, A., Paing, M. M., Temple, B. R. and Trejo, J. (2008). G protein-coupled receptor sorting to endosomes and lysosomes. Annu Rev Pharmacol Toxicol 48: 601-629.
Qin, K., Dong, C., Wu, G. and Lambert, N. A. (2011). Inactive-state preassembly of G_q-coupled receptors and G_q heterotrimers. Nat Chem Biol 7(10): 740-747.
Shiwarski, D. J., Crilly, S. E., Dates, A. and Puthenveedu, M. A. (2019). Dual RXR motifs regulate nerve growth factor-mediated intracellular retention of the delta opioid receptor. Mol Biol Cell 30(5): 680-690.
Shiwarski, D. J., Darr, M., Telmer, C. A., Bruchez, M. P. and Puthenveedu, M. A. (2017). PI3K class IIα regulates δ-opioid receptor export from the trans-Golgi network. Mol Biol Cell 28(16): 2202-2219.
Tan, C. M., Brady, A. E., Nickols, H. H., Wang, Q. and Limbird, L. E. (2004). Membrane trafficking of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 44: 559-609.
Wei, Z., Zhang, M., Li, C., Huang, W., Fan, Y., Guo, J., Khater, M., Fukuda, M., Dong, Z., Hu, G. and Wu, G. (2019). Specific TBC domain-containing proteins control the ER-Golgi-plasma membrane trafficking of GPCRs. Cell Rep 28(2): 554-566 e554.
Weinberg, Z. Y. and Puthenveedu, M. A. (2019). Regulation of G protein-coupled receptor signaling by plasma membrane organization and endocytosis. Traffic 20(2): 121-129.
Zhang, M., Davis, J. E., Li, C., Gao, J., Huang, W., Lambert, N. A., Terry, A. V., Jr. and Wu, G. (2016a). GGA3 interacts with a G protein-coupled receptor and modulates its cell surface export. Mol Cell Biol 36(7): 1152-1163.
Zhang, M., Huang, W., Gao, J., Terry, A. V. and Wu, G. (2016b). Regulation of alpha2B-adrenergic receptor cell surface transport by GGA1 and GGA2. Sci Rep 6: 37921.
Zhang, M. and Wu, G. (2019). Mechanisms of the anterograde trafficking of GPCRs: Regulation of AT1R transport by interacting proteins and motifs. Traffic 20(2): 110-120.
Zhang, M., Xu, X., Li, C., Huang, W., Xu, N. and Wu, G. (2019). A naturally occurring splice variant of GGA1 inhibits the anterograde Post-Golgi traffic of α_2B-adrenergic receptor. Sci Rep 9(1): 10378.
Zhang, X., Dong, C., Wu, Q. J., Balch, W. E. and Wu, G. (2011). Di-acidic motifs in the membrane-distal C termini modulate the transport of angiotensin II receptors from the endoplasmic reticulum to the cell surface. J Biol Chem 286(23): 20525-20535.
Zhu, S., Zhang, M., Davis, J. E., Wu, W. H., Surrao, K., Wang, H. and Wu, G. (2015). A single mutation in helix 8 enhances the angiotensin II type 1a receptor transport and signaling. Cell Signal 27(12): 2371-2379.